226 related articles for article (PubMed ID: 27249616)
1. Sirt 1 activator attenuates the bleomycin-induced lung fibrosis in mice via inhibiting epithelial-to-mesenchymal transition (EMT).
Rong L; Wu J; Wang W; Zhao RP; Xu XW; Hu D
Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2144-50. PubMed ID: 27249616
[TBL] [Abstract][Full Text] [Related]
2. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
3. Phenylbutyric acid inhibits epithelial-mesenchymal transition during bleomycin-induced lung fibrosis.
Zhao H; Qin HY; Cao LF; Chen YH; Tan ZX; Zhang C; Xu DX
Toxicol Lett; 2015 Jan; 232(1):213-20. PubMed ID: 25455454
[TBL] [Abstract][Full Text] [Related]
4. Ephedrine alleviates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition and restraining NF-κB signaling.
Tian H; Wang L; Fu T
J Toxicol Sci; 2023; 48(10):547-556. PubMed ID: 37778983
[TBL] [Abstract][Full Text] [Related]
5. Calpain inhibition attenuates bleomycin-induced pulmonary fibrosis via switching the development of epithelial-mesenchymal transition.
Liu Y; Liu B; Zhang GQ; Zou JF; Zou ML; Cheng ZS
Naunyn Schmiedebergs Arch Pharmacol; 2018 Jul; 391(7):695-704. PubMed ID: 29666896
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
Gao L; Jiang D; Geng J; Dong R; Dai H
Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
[TBL] [Abstract][Full Text] [Related]
7. Calcitriol inhibits bleomycin-induced early pulmonary inflammatory response and epithelial-mesenchymal transition in mice.
Tan ZX; Chen YH; Xu S; Qin HY; Zhang C; Zhao H; Xu DX
Toxicol Lett; 2016 Jan; 240(1):161-71. PubMed ID: 26520185
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
Divya T; Velavan B; Sudhandiran G
Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):122-129. PubMed ID: 29394529
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of PIM1 kinase attenuates bleomycin-induced pulmonary fibrosis in mice by modulating the ZEB1/E-cadherin pathway in alveolar epithelial cells.
Zhang X; Zou Y; Liu Y; Cao Y; Zhu J; Zhang J; Chen X; Zhang R; Li J
Mol Immunol; 2020 Sep; 125():15-22. PubMed ID: 32619930
[TBL] [Abstract][Full Text] [Related]
11. Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis.
Tong B; Fu L; Hu B; Zhang ZC; Tan ZX; Li SR; Chen YH; Zhang C; Wang H; Xu DX; Zhao H
BMC Pulm Med; 2021 May; 21(1):149. PubMed ID: 33952237
[TBL] [Abstract][Full Text] [Related]
12. β-carboline alkaloids attenuate bleomycin induced pulmonary fibrosis in mice through inhibiting NF-kb/p65 phosphorylation and epithelial-mesenchymal transition.
Cui Y; Jiang L; Yu R; Shao Y; Mei L; Tao Y
J Ethnopharmacol; 2019 Oct; 243():112096. PubMed ID: 31323300
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/Smad2/3-mediated epithelial-mesenchymal transition.
Li SR; Tan ZX; Chen YH; Hu B; Zhang C; Wang H; Zhao H; Xu DX
Respir Res; 2019 Nov; 20(1):266. PubMed ID: 31775746
[TBL] [Abstract][Full Text] [Related]
14. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G
Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714
[TBL] [Abstract][Full Text] [Related]
16. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.
Li LF; Kao KC; Liu YY; Lin CW; Chen NH; Lee CS; Wang CW; Yang CT
J Cell Mol Med; 2017 Nov; 21(11):2937-2949. PubMed ID: 28598023
[TBL] [Abstract][Full Text] [Related]
17. Detection of epithelial to mesenchymal transition in airways of a bleomycin induced pulmonary fibrosis model derived from an alpha-smooth muscle actin-Cre transgenic mouse.
Wu Z; Yang L; Cai L; Zhang M; Cheng X; Yang X; Xu J
Respir Res; 2007 Jan; 8(1):1. PubMed ID: 17207287
[TBL] [Abstract][Full Text] [Related]
18. Probucol ameliorates EMT and lung fibrosis through restoration of SIRT3 expression.
Zhang HX; Li YN; Wang XL; Ye CL; Zhu XY; Li HP; Yang T; Liu YJ
Pulm Pharmacol Ther; 2019 Aug; 57():101803. PubMed ID: 31085231
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol ameliorates lipopolysaccharide-induced epithelial mesenchymal transition and pulmonary fibrosis through suppression of oxidative stress and transforming growth factor-β1 signaling.
Zhang YQ; Liu YJ; Mao YF; Dong WW; Zhu XY; Jiang L
Clin Nutr; 2015 Aug; 34(4):752-60. PubMed ID: 25234611
[TBL] [Abstract][Full Text] [Related]
20. Neutralization of IL-18 by IL-18 binding protein ameliorates bleomycin-induced pulmonary fibrosis via inhibition of epithelial-mesenchymal transition.
Zhang LM; Zhang Y; Fei C; Zhang J; Wang L; Yi ZW; Gao G
Biochem Biophys Res Commun; 2019 Jan; 508(2):660-666. PubMed ID: 30527805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]